Success Metrics

Completion Rate
0%(0/1)
Active Trials
1(33%)
Terminated
1(33%)

Phase Distribution

Ph phase_1
1
33%
Ph phase_3
2
67%

Phase Distribution

1

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
Phase 3Large-scale testing
2(66.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Terminated(1)
Other(1)

Detailed Status

Terminated1
unknown1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
0.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (33.3%)
Phase 32 (66.7%)

Trials by Status

terminated133%
unknown133%
active_not_recruiting133%

Recent Activity

1 active trials
Showing 3 of 3
active_not_recruitingphase_1

A Study Assessing KB304 for the Treatment of Wrinkles in Women

NCT06724900
unknownphase_3

Efficacy of Continuous Terlipressin Therapy After Endoscopic Variceal Ligation

NCT06027970
terminatedphase_3

Hypertonic Resuscitation Following Severe Traumatic Brain Injury (TBI)

NCT00316004

Clinical Trials (3)

Showing 3 of 3 trials
NCT06724900Phase 1

A Study Assessing KB304 for the Treatment of Wrinkles in Women

Active Not Recruiting
NCT06027970Phase 3

Efficacy of Continuous Terlipressin Therapy After Endoscopic Variceal Ligation

Unknown
NCT00316004Phase 3

Hypertonic Resuscitation Following Severe Traumatic Brain Injury (TBI)

Terminated

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3